351 related articles for article (PubMed ID: 17182759)
21. Linezolid resistant enterococcus faecium.
McNicholas S; Hanahoe B; Higgins F; McAnena O; Corbett-Feeney G; Cormican M
Ir Med J; 2008; 101(7):225-6. PubMed ID: 18810787
[No Abstract] [Full Text] [Related]
22. Cerebrospinal fluid penetration and bacteriostatic activity of linezolid against Enterococcus faecalis in a child with a ventriculoperitoneal shunt infection.
Milstone AM; Dick J; Carson B; Siberry GK
Pediatr Neurosurg; 2007; 43(5):406-9. PubMed ID: 17786008
[TBL] [Abstract][Full Text] [Related]
23. [Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium].
Berberian G; Castro G; Fistolera S; Travaglianti M; Lopardo H; Mastroianni A; Rosanova MT
Rev Argent Microbiol; 2009; 41(1):34-8. PubMed ID: 19391524
[TBL] [Abstract][Full Text] [Related]
24. Single center experience of a vancomycin resistant enterococcal endocarditis cohort.
Forrest GN; Arnold RS; Gammie JS; Gilliam BL
J Infect; 2011 Dec; 63(6):420-8. PubMed ID: 21920382
[TBL] [Abstract][Full Text] [Related]
25. Vancomycin-resistant Enterococcus faecium endocarditis in a premature infant successfully treated with linezolid.
Ang JY; Lua JL; Turner DR; Asmar BI
Pediatr Infect Dis J; 2003 Dec; 22(12):1101-3. PubMed ID: 14688576
[TBL] [Abstract][Full Text] [Related]
26. [Enterococcus faecalis meningitis after spinal anesthesia successfully managed with linezolid].
Cournac JM; Landais C; Gaillard T; Bordes J; Carli P
Med Mal Infect; 2012 Jul; 42(7):327-8. PubMed ID: 22727505
[No Abstract] [Full Text] [Related]
27. Increasing incidence of linezolid-intermediate or -resistant, vancomycin-resistant Enterococcus faecium strains parallels increasing linezolid consumption.
Scheetz MH; Knechtel SA; Malczynski M; Postelnick MJ; Qi C
Antimicrob Agents Chemother; 2008 Jun; 52(6):2256-9. PubMed ID: 18391028
[TBL] [Abstract][Full Text] [Related]
28. Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.
Schülin T; Thauvin-Eliopoulos C; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 1999 Dec; 43(12):2873-6. PubMed ID: 10582874
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of Enterococcus faecalis prosthetic valve endocarditis with linezolid.
Rao N; White GJ
Clin Infect Dis; 2002 Oct; 35(7):902-4. PubMed ID: 12228838
[No Abstract] [Full Text] [Related]
30. Short course of linezolid treatment for vancomycin-resistant Enterococcus faecium meningitis.
Tsai TN; Wu CP; Peng MY; Giian CF; Lee SY; Lu JJ
Int J Clin Pract; 2006 Jun; 60(6):740-1. PubMed ID: 16805761
[TBL] [Abstract][Full Text] [Related]
31. Central venous catheter colonization by linezolid-resistant, vancomycin-susceptible Enterococcus faecalis.
Marra AR; Major Y; Edmond MB
J Clin Microbiol; 2006 May; 44(5):1915-6. PubMed ID: 16672440
[TBL] [Abstract][Full Text] [Related]
32. Linezolid in prophylaxis against experimental aortic valve endocarditis due to Streptococcus oralis or Enterococcus faecalis.
Athanassopoulos G; Pefanis A; Sakka V; Iliopoulos D; Perrea D; Giamarellou H
Antimicrob Agents Chemother; 2006 Feb; 50(2):654-7. PubMed ID: 16436723
[TBL] [Abstract][Full Text] [Related]
33. Linezolid for treatment of vancomycin-resistant enterococcal peritonitis.
Bailey EM; Faber MD; Nafziger DA
Am J Kidney Dis; 2001 Oct; 38(4):E20. PubMed ID: 11576907
[TBL] [Abstract][Full Text] [Related]
34. Linezolid-resistant Enterococcus faecalis: first report in Spain.
Sánchez-Gómez JC; Fraile-Malmierca F; Valverdé-Romero ED; Sánchez M; García-Rodríguez JA; García-Sánchez JE
J Chemother; 2006 Aug; 18(4):440-2. PubMed ID: 17024804
[No Abstract] [Full Text] [Related]
35. Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence.
Falagas ME; Manta KG; Ntziora F; Vardakas KZ
J Antimicrob Chemother; 2006 Aug; 58(2):273-80. PubMed ID: 16735427
[TBL] [Abstract][Full Text] [Related]
36. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.
Chien JW; Kucia ML; Salata RA
Clin Infect Dis; 2000 Jan; 30(1):146-51. PubMed ID: 10619743
[TBL] [Abstract][Full Text] [Related]
37. Successful use of intravenous linezolid in CAPD patient with vancomycin-resistant enterococcal peritonitis.
Yang JW; Kim YS; Choi SO; Han BG
Perit Dial Int; 2011; 31(2):209-10. PubMed ID: 21427253
[No Abstract] [Full Text] [Related]
38. A case of Streptococcus mitis endocarditis successfully treated by linezolid.
Ng KH; Lee S; Yip SF; Que TL
Hong Kong Med J; 2005 Oct; 11(5):411-3. PubMed ID: 16219964
[TBL] [Abstract][Full Text] [Related]
39. Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.
Swoboda S; Fritz S; Martignoni ME; Feldhues RA; Hoppe-Tichy T; Buchler MW; Geiss HK
J Antimicrob Chemother; 2005 Oct; 56(4):787-9. PubMed ID: 16143710
[TBL] [Abstract][Full Text] [Related]
40. Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: case report and review of the literature.
Zeana C; Kubin CJ; Della-Latta P; Hammer SM
Clin Infect Dis; 2001 Aug; 33(4):477-82. PubMed ID: 11462183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
